Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hitzenberger

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The American Journal of Cardiology|July 13, 1995
Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitusS Appel, T Rüfenacht, G Kalafsky, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1982
Duration of the hypotensive effect of guanfacineD Magometschnigg, J Bonelli, A Gassner, et al.
Wiener Medizinische Wochenschrift. Supplement|January 1, 1985
[Treatment of medium-severe essential hypertension with beta-Aldopur under practice conditions]G Tutsch, G Guberner, R Nitsch-Fitz, et al.
Journal of Clinical Pharmacology|October 1, 1993
Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministrationE A Mueller, J M Kovarik, E U Koelle, et al.
Wiener Medizinische Wochenschrift (1946)|November 30, 1987
[Prazosin in the treatment of hypertension: effect on lipid metabolism]G Hitzenberger, K Neumann, S Dietz, et al.
Clinical Pharmacology and Therapeutics|March 1, 1981
Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratioJ A Tobert, V J Cirillo, G Hitzenberger, et al.
Journal of Clinical Pharmacology|June 1, 1988
Cardioselectivity of cetamolol compared with atenolol and nadololM A Klausner, D F Ventura, J Coelho, et al.
Advances in Therapy|September 30, 2000
Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial InvestigatorsV H Monterroso, V Rodriguez Chavez, E T Carbajal, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combinationR G Asmar, G M London, M E O'Rourke, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The American Journal of Cardiology|July 13, 1995
Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitusS Appel, T Rüfenacht, G Kalafsky, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1982
Duration of the hypotensive effect of guanfacineD Magometschnigg, J Bonelli, A Gassner, et al.
Wiener Medizinische Wochenschrift. Supplement|January 1, 1985
[Treatment of medium-severe essential hypertension with beta-Aldopur under practice conditions]G Tutsch, G Guberner, R Nitsch-Fitz, et al.
Journal of Clinical Pharmacology|October 1, 1993
Pharmacokinetics of cyclosporine and multiple-dose diclofenac during coadministrationE A Mueller, J M Kovarik, E U Koelle, et al.
Wiener Medizinische Wochenschrift (1946)|November 30, 1987
[Prazosin in the treatment of hypertension: effect on lipid metabolism]G Hitzenberger, K Neumann, S Dietz, et al.
Clinical Pharmacology and Therapeutics|March 1, 1981
Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratioJ A Tobert, V J Cirillo, G Hitzenberger, et al.
Journal of Clinical Pharmacology|June 1, 1988
Cardioselectivity of cetamolol compared with atenolol and nadololM A Klausner, D F Ventura, J Coelho, et al.
Advances in Therapy|September 30, 2000
Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Losartan Trial InvestigatorsV H Monterroso, V Rodriguez Chavez, E T Carbajal, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combinationR G Asmar, G M London, M E O'Rourke, et al.
Pageof 8